Search

You searched for "correction"

3064 results found

The Lily Foundation celebrates approval of first ever mitochondrial disease treatment by NICE

14 August 2025 | Leber’s hereditary optic neuropathy, idebenone, Pharmacology, new therapies, research
The Lily Foundation, the UK’s leading mitochondrial disease charity, is today celebrating a landmark achievement in the fight against the disease – the first ever treatment for a mitochondrial condition has been approved for use on the NHS in England....

Researchers identify a novel genetic cause of Fuchs endothelial corneal dystrophy

2 October 2025 | cornea, genetics, research, novel therapies, age-related vision loss
Researchers identify a novel genetic cause of Fuchs endothelial corneal dystrophy, offering new ways for future therapies to target this common, age-related cause of visual loss. In a landmark study, researchers supported by NIHR Moorfields Biomedical Research Centre, have identified...

AI detects eye changes that lead to sight loss in young people

16 October 2025 | artificial intelligence, kerataconus, Moorfields, sight loss
Use of Artificial Intelligence (AI) can accurately predict when young people with the sight- threatening eye condition kerataconus need treatment to stabilise the cornea and prevent loss of vision. Developed by researchers at Moorfields Eye Hospital and UCL Institute of...

How to examine the visual system Part 2: Accommodation, pupils, fundoscopy and additional tests

1 August 2014 | | EYE - Vitreo-Retinal
Examining the visual system can be a tricky skill for medical students to master, yet it is a task that is frequently tested in examinations. This is the second of a two-part series of articles, which together aim to improve...

Retina Subspecialty Day highlights from the RCOphth 2026 Annual Congress

5 August 2026 | | EYE - Vitreo-Retinal
Implementation of biosimilars in NHS retinal services A NHS England (NHSE) perspective Luke Nicholson (Moorfields Eye Hospital) explained that the NHSE perspective overall is structured on best value medicine for the patient and system, accounting for a finite budget and...

What's trending Jun/Jul 2018

1 June 2018 | | EYE - General
A round-up of the eye-related hot topics that have been trending on social media over the last few weeks. #BusyPhillips #photokeratitis #sunglasses Last time, we were in the throes of the Beast from the East. Here in the UK, it’s...

It’s not all about ARED - Time for a pragmatic approach to nutrition for eye health?

1 April 2016 | | EYE - Cornea
Advances in treatment for retinal diseases involving neovascularisation have undoubtedly changed the future of eye care across the UK for the better, but also created great challenges for service delivery in ophthalmology, particularly within the NHS. Some statistics are starting...

Here comes the fear

2 June 2025 | | EYE - General
“At a cardiac arrest, the first procedure is to take your own pulse” The quote above is the Fat Man’s third law from the book The House of God by Samuel Shem, previously described in the ‘Doctor by the sea’...

Act now: Professor Serge Resnikoff on making myopia a public health priority

3 April 2026 | | EYE - Paediatrics, EYE - Refractive
Over the past decade, myopia has shifted from a common childhood inconvenience to what global health leaders now call a “public health emergency in slow motion” [1]. According to Professor Serge Resnikoff, former Head of Eye Health at the World...

Dec/Jan Quiz 2014

1 December 2013 | | EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
History A 25-year-old West African male presents with oral candidiasis, generalised lymphadenopathy and a red nodule in the left upper eyelid. This is biopsied. See histology images. Figure 1. Figure 2. Figure 3. Questions 1. Describe Figure 1 (haematoxylin and...

Recurrent corneal erosions secondary to isotretinoin use

7 December 2020 | | EYE - Cornea, EYE - Glaucoma
Isotretinoin (13–cis-retinoic acid) is the first line treatment for moderate to severe nodulocystic or papulopustular acne [1,2]. Although it is a safe medication, it has several adverse side-effects, including ophthalmic manifestations, as shown in Table 1 [3]. These side-effects need...

Andean Medical Mission in action 2025

8 October 2025 | | international, AMM, charity, South America, glaucoma
Dear friends and supporters, What 12 months it has been for the Andean Medical Mission! Thanks to your encouragement and generosity, we’ve been able to continue our work to eliminate avoidable blindness in the Beni region of Bolivia — and...